FIELD: biotechnology.
SUBSTANCE: method for cardio-generative potential determination in mammal cells is proposed, including collection of the measured levels of Nkx2.5, Tbx5, MEF2C, GATA4, GATA6, Mesp1, FOG1 genes expression in mammal cells, and cardio-generative potential coefficient (CARPI) determination as the average value of the measured levels expression of the genes of the said cells.
EFFECT: good predictability of heart recovery success.
13 cl, 1 dwg, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR TREATING CARDIAC DISEASES | 2010 |
|
RU2595801C2 |
| CELL COMPOSITIONS AND METHODS OF THEIR APPLICATION FOR TREATING CARDIAC TISSUE | 2009 |
|
RU2519762C2 |
| CELLS DERIVED FROM CARDIAC TISSUE | 2010 |
|
RU2662675C1 |
| CELLS DERIVED FROM CARDIAL TISSUE | 2010 |
|
RU2642282C1 |
| CELLS BEING DERIVATIVES OF CARDIAC TISSUE | 2010 |
|
RU2583287C2 |
| METHOD OF STEM CELLS DIFFERENTIATION INTO MIOCARDIAL CELLS INDUCTION | 2004 |
|
RU2392315C2 |
| REPROGRAMMING HUMAN ENDOTHELIUM IN HEMATOPOIETIC PRECURSORS OF MULTIPLE LINES OF DIFFERENTIATION USING CERTAIN FACTORS | 2014 |
|
RU2691062C2 |
| METHOD OF CONSTRUCTING MASS OF MYOCARDIAL CELLS AND USE OF MASS OF MYOCARDIAL CELLS | 2008 |
|
RU2467066C2 |
| SERUM-FREE MEDIUM FOR CULTURED CELLS USED FOR RECONSTRUCTION OF OSSEOUS AND CARTILAGE SEGMENTS (VARIANTS) | 1999 |
|
RU2272839C2 |
| METHOD OF ESTIMATING ANGIOGENIC POTENTIAL OF PROGENOTOR CELLS IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2011 |
|
RU2548801C2 |
